Preventing Early-Onset Colorectal Cancer in the VA

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-49
SponsorVA Office of Research and Development

About this trial

Colorectal cancer is a leading cause of cancer death among Veterans. The starting age for colorectal cancer screening has been lowered from 50 to 45 years in response to the rising incidence of early-onset colorectal cancer (EOCRC), but how to best engage younger Veterans in screening is unclear. The investigators will 1) develop and validate a novel risk score for EOCRC derived from the VA electronic health record data, 2) conduct a multilevel screening intervention that targets individuals aged 45-49 years and informs high-risk individuals and their providers about their risk status for EOCRC, and 3) determine barriers and facilitators to implementing the intervention using a qualitative process evaluation. Aim 2 is the focus of the trial. The overall goal of this study is to create and test a risk stratification approach to prevent EOCRC, which may be especially useful for younger individuals who are less likely to participate in preventive care.

Eligibility criteria

Qualifiers

Age 45-49 years at screening

Disqualifiers

Up-to-date with CRC screening based on the USPSTF guideline (e.g., colonoscopy within the past 10 years or FIT within the past year)

Prior CRC diagnosis

Prior total colectomy

Limited life expectancy (defined as terminal illness, hospice enrollment, or documented life expectancy <6 months on the medical problem list or a health factor in the EHR

Trial design

Treatments tested in this trial

  • Patient intervention
  • PCP intervention

Treatment groups

536 Participants
are divided into 4 treatment groups

Locations

1
VA NY Harbor Healthcare System, New York, NY10010-5011, New YorkNew York, United States

Sponsors and collaborators

VA Office of Research and Development

Lead sponsor